Cost-utility analysis of treatments for stage IB cervical cancer
Open Access
- 1 January 2014
- journal article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 25 (2) , 97-104
Abstract
Katanyoo K, et al. J Gynecol Oncol. 2014 Apr;25(2):97-104. https://doi.org/10.3802/jgo.2014.25.2.97Keywords
Funding Information
- Thai Health Promotion Foundation
- Faculty of Medicine Vajira Hospital, Navamindradhiraj University
This publication has 28 references indexed in Scilit:
- Comparative Effectiveness Research in Oncology: An OverviewJournal of Clinical Oncology, 2012
- Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervixGynecologic Oncology, 2012
- Estimating Population-Based Values for EQ-5D Health States in ThailandValue in Health, 2011
- Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trialAmerican Journal of Obstetrics and Gynecology, 2007
- Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancerJournal of Obstetrics and Gynaecology Research, 2006
- Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical–pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trialGynecologic Oncology, 2005
- A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?Gynecologic Oncology, 2004
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997
- Radical hysterectomy versus radiation therapy for stage ib squamous cell cancer of the cervixCancer, 1991
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990